Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Inside IC System’s Successful Partnership with Genomind

Bryan Campbell, Business Development Manager with IC System, and Tom Hess, Senior Vice President and Chief Financial Officer of Genomind, join Tyler Kern to discuss the companies’ successful working relationship forged during the COVID-19 pandemic.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Finding a perfect match can be difficult, but sometimes things just click. That’s the case with IC System and Genomind.

Genomind, a company utilizing genetics as a data point in diagnosing mental health challenges, wanted a recovery agency that, instead of aggressively going after those who hadn’t yet paid for the services provided, would take a tactful approach.

“We didn’t set any goals other than we didn’t want patients to be upset and didn’t want them to call the doctors and upset the doctors, which would cascade into them calling our sales reps,” said Thomas Hess, Senior Vice President and Chief Financial Officer of Genomind. “We had zero expectations for collections. Our goal was just not to upset people.”

Genomind had chatted with other companies in the same space as IC System and ran a pilot with IC once Hess found the IC System website and was impressed with the transparency, family-oriented nature of the business and site design.

Rather than simply not upsetting people, Genomind found a success rate that far outpaced their goals, leading to millions of dollars added in revenue and recovery.

Genomind was an ideal client for IC System, said Bryan Campbell, Business Development Manager, since IC System is always happy to modify its approach and work with each client on an individual basis.

The partnership looked a bit different during the pandemic, but the companies were able to come together using virtual meeting platforms to make sure everyone was reaching their goals.

“Everybody’s doing the same thing, but we at IC System, from a sales standpoint, say that everybody is operating at the same way. You’ve got to do it better,” he said. “You have to build those relationships and make sure those carry through in a new way and stronger way.

“We just got after that. They were real treats to able to get on, to use the new technology and depend on it rather than just being on the phone. It’s like we haven’t missed a beat.”

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512